Ropes & Gray Advises Athyrium Capital in Agreement to Sell Alcresta Therapeutics
March 15, 2024
March 15, 2024
BOSTON, Massachusetts, March 15 -- Ropes and Gray, a law firm, issued the following news:
Attorneys:Taylor J. Hart, Graham Foster, Adam D. Greenwood, Kyle Higley
Ropes & Gray advised Athyrium Capital in connection with the sale of Alcresta Therapeutics, which develops novel products that deliver enzymatic solutions to those living with rare diseases. The transaction closed on March 12 and was announced in a press release.
Athyrium is a specialized asset . . .
Attorneys:Taylor J. Hart, Graham Foster, Adam D. Greenwood, Kyle Higley
Ropes & Gray advised Athyrium Capital in connection with the sale of Alcresta Therapeutics, which develops novel products that deliver enzymatic solutions to those living with rare diseases. The transaction closed on March 12 and was announced in a press release.
Athyrium is a specialized asset . . .